Could Orkambi lead the way for better cystic fibrosis treatments?
Australia recently became the eighth country to approve and provide a drug that can extend the lives of those living with certain types of cystic fibrosis.
The drug Orkambi once cost 250-thousand-dollars a year but should now be affordable for hundreds of families dealing with the genetic condition.
But there’s a growing realisation here and in other countries that it may not be the miracle drug the cystic fibrosis community is pinning its hopes on and instead could pave the way for other more effective treatments.
Click here to listen to the original audio story from AM.